Zürcher Nachrichten - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.31683
AFN 75.228656
ALL 95.068131
AMD 432.88885
ANG 2.103914
AOA 1079.059869
ARS 1643.281536
AUD 1.624521
AWG 2.118743
AZN 1.991897
BAM 1.948996
BBD 2.361158
BDT 143.847849
BGN 1.960765
BHD 0.442655
BIF 3489.319312
BMD 1.175447
BND 1.486511
BOB 8.100722
BRL 5.763923
BSD 1.172308
BTN 110.704547
BWP 15.739057
BYN 3.312935
BYR 23038.755179
BZD 2.357769
CAD 1.608505
CDF 2662.386498
CHF 0.915908
CLF 0.026661
CLP 1049.297515
CNY 7.99392
CNH 7.984785
COP 4406.77316
CRC 538.918716
CUC 1.175447
CUP 31.149337
CVE 109.881421
CZK 24.321109
DJF 208.761246
DKK 7.473067
DOP 69.71663
DZD 155.469647
EGP 61.803693
ERN 17.6317
ETB 183.048306
FJD 2.570526
FKP 0.862123
GBP 0.865123
GEL 3.14435
GGP 0.862123
GHS 13.2059
GIP 0.862123
GMD 86.401959
GNF 10286.092801
GTQ 8.950754
GYD 245.283751
HKD 9.203248
HNL 31.165207
HRK 7.53743
HTG 153.48421
HUF 354.855317
IDR 20475.693665
ILS 3.425131
IMP 0.862123
INR 111.903699
IQD 1535.738967
IRR 1541598.337446
ISK 143.804144
JEP 0.862123
JMD 184.765013
JOD 0.833364
JPY 184.699082
KES 151.80888
KGS 102.758144
KHR 4703.580509
KMF 491.336451
KPW 1057.901973
KRW 1733.5845
KWD 0.361799
KYD 0.976989
KZT 541.818593
LAK 25709.252874
LBP 104981.226364
LKR 377.43244
LRD 215.119052
LSL 19.232562
LTL 3.470789
LVL 0.711016
LYD 7.413122
MAD 10.721772
MDL 20.047019
MGA 4896.905641
MKD 61.66263
MMK 2467.881405
MNT 4204.228756
MOP 9.452303
MRU 46.857428
MUR 54.928689
MVR 18.102674
MWK 2032.40518
MXN 20.243366
MYR 4.618341
MZN 75.122928
NAD 19.232562
NGN 1596.209455
NIO 43.139407
NOK 10.809994
NPR 177.127674
NZD 1.977548
OMR 0.451959
PAB 1.172308
PEN 4.053251
PGK 5.176928
PHP 71.820961
PKR 326.72565
PLN 4.240594
PYG 7161.002021
QAR 4.285042
RON 5.221219
RSD 117.39068
RUB 87.569554
RWF 1718.600624
SAR 4.428479
SBD 9.426415
SCR 17.186198
SDG 705.853791
SEK 10.880463
SGD 1.492464
SHP 0.87759
SLE 28.974525
SLL 24648.524918
SOS 669.961266
SRD 43.960489
STD 24329.373323
STN 24.414772
SVC 10.25819
SYP 129.943205
SZL 19.219906
THB 38.155068
TJS 10.937718
TMT 4.114063
TND 3.405113
TOP 2.830194
TRY 53.338599
TTD 7.945264
TWD 36.929038
TZS 3067.915591
UAH 51.495537
UGX 4392.665866
USD 1.175447
UYU 46.756779
UZS 14220.358871
VES 586.82527
VND 30943.634188
VUV 139.381869
WST 3.182048
XAF 653.675119
XAG 0.014665
XAU 0.000252
XCD 3.176703
XCG 2.112824
XDR 0.812962
XOF 653.675119
XPF 119.331742
YER 280.490981
ZAR 19.363135
ZMK 10580.421228
ZMW 22.319087
ZWL 378.493355
  • CMSD

    0.1140

    23.534

    +0.48%

  • JRI

    0.0000

    13.15

    0%

  • BCC

    -2.0900

    70.67

    -2.96%

  • BTI

    0.2000

    58.28

    +0.34%

  • RIO

    2.2700

    105.38

    +2.15%

  • GSK

    -0.0900

    50.41

    -0.18%

  • CMSC

    0.1400

    23.11

    +0.61%

  • BP

    -0.4700

    43.34

    -1.08%

  • BCE

    -0.4300

    24.14

    -1.78%

  • NGG

    0.9800

    86.89

    +1.13%

  • RBGPF

    0.7000

    63.61

    +1.1%

  • AZN

    0.3300

    182.85

    +0.18%

  • RYCEF

    -0.4100

    16.37

    -2.5%

  • VOD

    0.5100

    16.2

    +3.15%

  • RELX

    0.0759

    33.58

    +0.23%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

F.Schneider--NZN